Nexo Therapeutics, Inc.

Biotech Littleton, CO

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Littleton, CO
Street
11757 W. Ken Caryl Avenue
Zip
80127-3719

Offering

Total offering
$60M
Amount sold
$60M
First sale
Nov 15, 2022
Min investment
$0
Securities
Equity, Debt
Federal exemption
Rule 506(b)
Investors so far
7

How this filing compares

Ranked #2 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 11.1× the median.

Other Colorado filings this week: BEAR CREEK STRATEGIC REAL ASSETS FUND LP, Delta-v PX, LP, FusionFX Fund, LLC, Glory LLC, Hannah Grey Ventures II, LP

Leadership

Andrew Phillips — Executive Officer (also: Director)

Ali Behbahani — Director

Carlo Rizzuto — Director

Filing details

Nexo Therapeutics, Inc. filed a Form D with the SEC on March 27, 2026.

Other newest Biotech companies

Other newest companies in Colorado